EB
AXSM icon

Eastern Bank’s Axsome Therapeutics AXSM Stock Holding History

Eastern Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-114
Closed -$19.3K – 1048
2026
Q1 		$19.3K Hold
114
– – ﹤0.01% 729
2025
Q4 		$20.8K Buy
+114
New +$15.9K ﹤0.01% 728

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Eastern Bank's AXSM Position: Q2 2026 in Review

Eastern Bank sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 114 shares — an estimated $19.3K sold.

Eastern Bank first reported a position in AXSM in Q4 2025 and held it in 2 quarters. The position peaked at $20.8K in Q4 2025. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Eastern Bank reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Eastern Bank sold 114 Axsome Therapeutics shares in Q2 2026, an estimated $19.3K.
  • Eastern Bank first reported a position in Axsome Therapeutics in Q4 2025 and held it in 2 quarters.
  • Eastern Bank's Axsome Therapeutics position peaked at $20.8K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.